Published in Arch Dis Child on March 01, 1993
Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed (2000) 2.70
The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Arch Dis Child (1993) 1.03
Prevention and management of neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed (1994) 0.96
Neonatal blood glucose concentrations: metabolic effects of intravenous glucagon and intragastric medium chain triglyceride. Arch Dis Child (1993) 0.86
Hyperinsulinaemic hypoglycaemia in preterm neonates. Arch Dis Child Fetal Neonatal Ed (2004) 0.77
Neonatal hypoglycaemia in Nepal 2. Availability of alternative fuels. Arch Dis Child Fetal Neonatal Ed (2000) 0.77
Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study). PLoS Med (2016) 0.75
Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes (1977) 2.02
Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child (1992) 1.73
Persistent glucose production during glucose infusion in the neonate. J Clin Invest (1983) 1.18
Role of glucose in the regulation of endogenous glucose production in the human newborn. Pediatr Res (1986) 1.07
Metabolic adaptation in small for gestational age infants. Arch Dis Child (1993) 1.05
The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Arch Dis Child (1993) 1.03
Spontaneous and amino acid-stimulated glucagon secretion in the immediate postnatal period. Relation to glucose and insulin. J Clin Invest (1974) 1.02
Gluconeogenesis in late fetal and early neonatal life. Biol Neonate (1986) 1.02
Neonatal changes in the concentration of rat liver cyclic AMP and of serum glucose, free fatty acids, insulin, pancreatic, and total glucagon in man and in the rat. J Lab Clin Med (1974) 1.01
Suppression of gluconeogenesis and endogenous glucose production by exogenous insulin administration in the newborn lamb. Pediatr Res (1979) 0.90
Hypoglycemia and hyperglycemia in tiny infants. Clin Perinatol (1986) 0.89
Relationship between glucose utilization rate and glucose concentration in preterm infants. Biol Neonate (1986) 0.87
Glucoregulation in the newborn. Can J Physiol Pharmacol (1980) 0.87
Neonatal blood glucose concentrations: metabolic effects of intravenous glucagon and intragastric medium chain triglyceride. Arch Dis Child (1993) 0.86
Stable isotope tracers and the determination of fuel fluxes in newborn infants. Biol Neonate (1987) 0.86
Gastrointestinal peptides and the adaptation to extrauterine nutrition. Can J Physiol Pharmacol (1985) 0.85
Insulin and growth-hormone responses in neonatal hyperglycemia. Diabetes (1976) 0.84
Inhibition of glucagon secretion in the human newborn by glucose infusion. Diabetes (1983) 0.81
Glucose homeostasis in preterm rhesus monkey neonates. Pediatr Res (1977) 0.81
The role of hepatic control of glucose homeostasis in the etiology of neonatal hypo- and hyperglycemia. Semin Perinatol (1979) 0.81
Ontogeny of glucose homeostasis in low birth weight infants. J Pediatr (1988) 0.81
Glucose disposal in low-birth-weight infants during steady-state hyperglycemia: effects of exogenous insulin administration. Pediatrics (1978) 0.80
Effect of theophylline, glucagon and theophylline plus glucagon on insulin secretion in the premature infant. Diabetes (1970) 0.79
Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial. Lancet (2000) 4.55
Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ (1997) 4.51
Avoidable factors contributing to death of children with head injury. BMJ (1990) 4.33
Causes of fatal childhood accidents involving head injury in northern region, 1979-86. BMJ (1990) 3.29
Observations on central and peripheral temperatures in the understanding and management of shock. Br J Surg (1969) 3.11
What is a normal rate of weight gain in infancy? Acta Paediatr (1994) 2.95
A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet (2000) 2.87
Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics (2000) 2.73
Measuring exposure to injury risk in schoolchildren aged 11-14. BMJ (1994) 2.52
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med (1996) 2.40
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Comparison of the use of Tanner and Whitehouse, NCHS, and Cambridge standards in infancy. Arch Dis Child (1993) 2.30
Unethical age assessment. Br Dent J (2009) 2.25
Neural dysfunction during hypoglycaemia. Arch Dis Child (1988) 2.19
Mammalian mitochondrial beta-oxidation. Biochem J (1996) 2.06
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest (2001) 2.01
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet (1999) 1.99
Annual incidence of unintentional injury among 54,000 children. Inj Prev (1996) 1.91
Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet (1987) 1.78
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child (1992) 1.73
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet (1998) 1.65
Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet (2001) 1.64
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med (1997) 1.55
Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting. Pediatrics (1990) 1.52
Contribution of aminoacid catabolism to propionate production in methylmalonic acidaemia. Lancet (1989) 1.50
Lymphocyte subpopulations in the blood of newborn infants. Clin Exp Immunol (1974) 1.48
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46
Neonatal hypoglycaemia--the controversy regarding definition. Arch Dis Child (1988) 1.44
Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet (1987) 1.43
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. Arch Dis Child (1980) 1.42
p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes (2001) 1.42
Biotinidase deficiency: a survey of 10 cases. Arch Dis Child (1988) 1.40
Effect of deprivation on weight gain in infancy. Acta Paediatr (1994) 1.40
Use of central and peripheral temperature measurements in care of the critically ill child. Arch Dis Child (1974) 1.38
Management of hyperinsulinism in infancy and childhood. Ann Med (2000) 1.33
Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants. Arch Dis Child (1978) 1.32
Cryptococcus gattii in wildlife of Vancouver Island, British Columbia, Canada. J Wildl Dis (2006) 1.28
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res (1991) 1.25
Development of gut hormone responses to feeding in neonates. Arch Dis Child (1980) 1.24
Gut hormones and 'minimal enteral feeding'. Acta Paediatr Scand (1986) 1.23
Metabolic and endocrine responses to a milk feed in six-day-old term infants: differences between breast and cow's milk formula feeding. Acta Paediatr Scand (1981) 1.23
Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand (1981) 1.20
Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest (1992) 1.20
Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. N Engl J Med (1984) 1.18
Does halothane anaesthesia decrease the metabolic and endocrine stress responses of newborn infants undergoing operation? Br Med J (Clin Res Ed) (1988) 1.16
Non-invasive assessment of intraluminal lipolysis using a 13CO2 breath test. Arch Dis Child (1990) 1.16
Measuring the severity of surgical stress in newborn infants. J Pediatr Surg (1988) 1.16
Combined carboxylase defect: biotin-responsiveness in cultured fibroblasts. Lancet (1976) 1.15
Influence of the central nervous system on fetal lung development. Experimental study. Arch Dis Child (1977) 1.14
Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch Dis Child (1996) 1.14
Hormonal and metabolic response to hypoglycaemia in small for gestational age infants. Arch Dis Child (1993) 1.12
Postnatal surges in plasma gut hormones in term and preterm infants. Biol Neonate (1982) 1.12
Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. J Clin Invest (1998) 1.11
Physician explanations for failing to comply with "best practices". Eff Clin Pract (2001) 1.11
Spatial and temporal distribution of airborne Bacillus thuringiensis var. kurstaki during an aerial spray program for gypsy moth eradication. Environ Health Perspect (2001) 1.11
The mitochondrial trifunctional protein: centre of a beta-oxidation metabolon? Biochem Soc Trans (2000) 1.10
A sensitive fluorimetric rate assay for biotinidase using a new derivative of biotin, biotinyl-6-aminoquinoline. Anal Biochem (1984) 1.08
Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain. Pediatr Res (1989) 1.08
Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease. Arch Dis Child (1996) 1.08
The management and long term outcome of organic acidaemias. J Inherit Metab Dis (1984) 1.08
The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. Biochem Pharmacol (1983) 1.06
The specificity of glycine-N-acylase and acylglycine excretion in the organicacidaemias. Biochem Med (1974) 1.06
Postnatal development of multiple opioid receptors in the spinal cord and development of spinal morphine analgesia. Brain Res Dev Brain Res (1998) 1.06
Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia (1973) 1.05
Metabolic adaptation in small for gestational age infants. Arch Dis Child (1993) 1.05
Biotin-responsive alopecia and developmental regression. Lancet (1979) 1.04
Hepatic glycogen synthetase deficiency. Definition of syndrome from metabolic and enzyme studies on a 9-year-old girl. Arch Dis Child (1977) 1.03
The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Arch Dis Child (1993) 1.03
Can the human neonate mount an endocrine and metabolic response to surgery? J Pediatr Surg (1985) 1.03
Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation. Pediatr Res (1995) 1.01
Child with a defect in leucine metabolism associated with beta-hydroxyisovaleric aciduria and beta-methylcrotonylglycinuria. Arch Dis Child (1973) 1.01
Studies on the hormonal regulation of fuel metabolism in the human newborn infant undergoing anaesthesia and surgery. Horm Res (1985) 1.01
The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations. Biochem Pharmacol (1984) 1.01
Biotinidase deficiency and the eye and ear. Lancet (1983) 1.00
Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism. J Pediatr (1976) 1.00
Endocrine and metabolic response in the human newborn to first feed of breast milk. Arch Dis Child (1977) 1.00
Skeletal muscle mitochondrial beta-oxidation. A study of the products of oxidation of [U-14C]hexadecanoate by h.p.l.c. using continuous on-line radiochemical detection. Biochem J (1988) 1.00
Hypoketotic hypofattyacidaemic hypoinsulinaemic hypoglycaemia in a child with hemihypertrophy? A new syndrome. Horm Res (2004) 1.00
The control of mitochondrial oxidations by complex III in rat muscle and liver mitochondria. Implications for our understanding of mitochondrial cytopathies in man. J Biol Chem (1994) 0.99
Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J Biol Chem (1991) 0.99
Nesidioblastosis of the pancreas in infancy. Dev Med Child Neurol (1981) 0.98
Impaired mitochondrial beta-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. J Clin Invest (1990) 0.97
Management of childhood pyrexia using central and peripheral temperature recordings. Lancet (1973) 0.97
Cerebral blood flow and metabolism in children with severe head injury. Part 1: Relation to age, Glasgow coma score, outcome, intracranial pressure, and time after injury. J Neurol Neurosurg Psychiatry (1995) 0.97
Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy. J Biol Chem (1999) 0.96
Prevention and management of neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed (1994) 0.96
Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology (1994) 0.96
Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin. J Clin Invest (1997) 0.95
Congenital bilateral anorchia in childhood: a clinical, endocrine and therapeutic evaluation of twenty-one cases. Clin Endocrinol (Oxf) (1976) 0.95